Pedraza-Chaverri J - Search Results

1

A ketogenic diet attenuates acute and chronic ischemic kidney injury and reduces markers of oxidative stress and inflammation.

Rojas-Morales P, León-Contreras JC, Sánchez-Tapia M, Silva-Palacios A, Cano-Martínez A, González-Reyes S, Jiménez-Osorio AS, Hernández-Pando R, Osorio-Alonso H, Sánchez-Lozada LG, Tovar AR, Pedraza-Chaverri J, Tapia E. Rojas-Morales P, et al. Life Sci. 2022 Jan 15;289:120227. doi: 10.1016/j.lfs.2021.120227. Epub 2021 Dec 16. Life Sci. 2022. PMID: 34921866

2

Ischemia-reperfusion induced acute renal failure in the rat is ameliorated by the spin-trapping agent alpha-phenyl-N-tert-butyl nitrone (PBN).

Pedraza-Chaverri J, Tapia E, Bobadilla N. Pedraza-Chaverri J, et al. Ren Fail. 1992;14(4):467-71. doi: 10.3109/08860229209047654. Ren Fail. 1992. PMID: 1461997

3

Activity of serum enzymes in puromycin aminonucleoside-induced nephrotic syndrome.

Pedraza-Chaverri J, Cruz C, Tapia E, Peña JC. Pedraza-Chaverri J, et al. Ren Fail. 1992;14(4):523-31. doi: 10.3109/08860229209047661. Ren Fail. 1992. PMID: 1462003

4

Role of angiotensin II in the antinatriuresis that follows acute volume depletion.

Gamba G, Pedraza-Chaverrí J, Cervera J, Cruz C, Hernández-Pando R, Peña JC. Gamba G, et al. Rev Invest Clin. 1992 Jul-Sep;44(3):345-52. Rev Invest Clin. 1992. PMID: 1488579

5

Effect of captopril on urinary excretion of renin and angiotensinogen in aminonucleoside nephrosis.

Pedraza-Chaverri J, Cruz C, Sandoval AA, Tapia E, Peña JC. Pedraza-Chaverri J, et al. Ren Fail. 1992;14(2):155-9. doi: 10.3109/08860229209039125. Ren Fail. 1992. PMID: 1636021

6

Urinary excretion of renin and angiotensinogen in nephrotic rats.

Pedraza-Chaverrí J, Cruz C, Ibarra-Rubio ME, Hernández C, Tapia E, Peña JC. Pedraza-Chaverrí J, et al. Nephron. 1991;57(1):106-8. doi: 10.1159/000186226. Nephron. 1991. PMID: 2046802

7

Serum angiotensin converting enzyme activity and plasma renin activity in experimental models of rats.

Ibarra-Rubio ME, Cruz C, Tapia E, Peña JC, Pedraza-Chaverrí J. Ibarra-Rubio ME, et al. Clin Exp Pharmacol Physiol. 1990 Jun;17(6):391-9. doi: 10.1111/j.1440-1681.1990.tb01338.x. Clin Exp Pharmacol Physiol. 1990. PMID: 2167778

8

Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. I. The role of proteinuria, hypoproteinemia, and renin-angiotensin-aldosterone system on sodium retention.

Pedraza-Chaverrí J, Cruz C, Ibarra-Rubio ME, Chávez MT, Calleja C, Tapia E, del Carmen Uribe M, Romero L, Peña JC. Pedraza-Chaverrí J, et al. Rev Invest Clin. 1990 Jan-Mar;42(1):29-38. Rev Invest Clin. 1990. PMID: 2236972

9

Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. II. In vitro release of renin, angiotensinogen and aldosterone.

Pedraza-Chaverrí J, Cruz C, Chávez MT, López A, Ibarra-Rubio ME, Tapia E, Peña JC. Pedraza-Chaverrí J, et al. Rev Invest Clin. 1990 Apr-Jun;42(2):120-6. Rev Invest Clin. 1990. PMID: 2267444

10

Pathophysiology of experimental nephrotic syndrome induced by puromicyn aminonucleoside in rats. III. Effect of captopril, an angiotensin converting enzyme inhibitor, on proteinuria and sodium retention.

Pedraza-Chaverrí J, Cruz C, Chávez MT, Ibarra-Rubio ME, Tapia E, Peña JC. Pedraza-Chaverrí J, et al. Rev Invest Clin. 1990 Jul-Sep;42(3):210-6. Rev Invest Clin. 1990. PMID: 2270368

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

462 results

Search Page